MEDI DATA INTERNATIONAL INC
10KSB/A, 1996-08-19
MISCELLANEOUS RETAIL
Previous: WITTER DEAN CORNERSTONE FUND III, 10-Q/A, 1996-08-19
Next: MEDI DATA INTERNATIONAL INC, 10KSB/A, 1996-08-19



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                               Form 10-KSB/A NO. 2



[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934 [Fee Required]

                   For the fiscal year ended February 29, 1996

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
    SECURITIES   EXCHANGE   ACT  OF  1934  [No  Fee Required]

                For the transition period from_______ to________
                                   
                         Commission File No. 2-88678-NY

                          MEDI-DATA INTERNATIONAL, INC. 
                 (Name of small business issuer in its charter) 

        New York                                         11-2653474
(State or other jurisdiction                     (I.R.S. Employer 
 of incorporation)                               Identification No.)

                20 Red Ground Road, Old Westbury, New York 11568
                    (Address of principal executive offices)

                    Issuer's telephone number: (516) 997-1155
       Securities registered under Section 12(b) of the Exchange Act: None
         Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock, $0.001 Par Value 
                                (Title of Class)

     Check  whether  the issuer (1) filed all  reports  required  to be filed by
section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.
Yes [ X ]    No [    ]


Number of shares outstanding of the issuer's common equity, as of August 1, 1996
      (exclusive of securities convertible into common equity) : 9,212,551


<PAGE>
This filing Form  10-KSB/A  No. 1 amends the Annual  Report on Form 10-KSB dated
May 28, 1996 of Medi-Data  International  Inc. (the  Company).  The  undersigned
Registrant hereby amends the following items, financial statements,  exhibits or
other  portions  of such  report on Form  10-KSB  dated May 28,  1996 (The "Form
10-KSB"), as set forth below:

Item 6. Management's  Discussion and Analysis of Financial Condition and Results
of Operations.

Results of Operations
The Company  ceased all  operations in April 1988,  however in 1995, the Company
invested in marketable securities which resulted in a realized gain for the year
ended February 29, 1996 of $74,004. For the fiscal year ended February 28, 1996,
the Company had net income of $2,665 versus a net loss of $29,192 for the fiscal
year ended  February 28, 1995. In January 1994 the Company  received a loan from
Terry Brooks, a principal shareholder, of $100,000 which was repaid in July 1995
from the proceeds of the sale of marketable  securities.  The loan bore interest
at ten percent per annum. In addition,  Terry Brooks' IRA assumed a $25,000 loan
from Marc Gold,  the former  president of the  company.  This loan bore the same
interest  rate and was also repaid in July 1995 from the proceeds of the sale of
the marketable securities.

Liquidity and Capital Resources

The Company  ceased all previous  operations  in April 1988,  and realized  only
interest income and gain on securities in the current period.  The company had a
net income for the fiscal  year ended  February  1996 of $2,665 and net loss for
the fiscal year ended 1995 of $29,193.  At the end of the fiscal year,  February
1996 and 1995,  the Company has a  shareholders'  deficiency of  $1,057,572  and
$1,060,235 respectively.

Item  11. Security Ownership of Certain Beneficial Owners and Management.

The following table sets forth the beneficial  ownership of the Company's common
stock as of May 1, 1996 for each person known by the Company to beneficially own
more than five percent of the shares of  outstanding  common Stock,  each of the
Company's directors, and each of the executive officers listed in Item 9.


Name of Individual                       No. of Shares          % of Outstanding
Or Identity of Group                       Owned (1)              Common Stock

Terry Brooks                              5,500,000 (2)                60%
Terry Brooks IRA                          2,500,000                    27%
=====
All Officers and Directors (2 people)     5,500,000 2                  60%

1 - Based on the  information  furnished  by the  beneficial  owners.  Except as
otherwise indicated herein, each beneficial owner has sole voting power and sole
investment power with respect to all shares owned.

2 - Includes  3,000,000  shares held by Ms.  Brooks as  custodian  for her minor
children.
<PAGE>
Item 12.  Certain Relationship and Related Transactions.

   
As noted in Item 6 the principal shareholder, Terry Brooks loaned to the Company
$100,000 in January 1994,  bearing interest at the rate of ten percent per annum
which was subsequently repaid in July of 1995. Ms. Brooks' IRA assumed a $25,000
loan from Marc Gold, the former president of the company.
    
This loan was at the same interest rate and was also repaid in July 1995.



<PAGE>






                                   SIGNATURES


Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed by the
undersigned, thereunto duly authorized.

Dated: August 1, 1996                              MEDI DATA INTERNATIONAL, INC.


                                                   /S/ TERRY BROOKS
                                                   Terry Brooks, President







<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          FEB-29-1996
<PERIOD-END>                               FEB-29-1996
<CASH>                                             845
<SECURITIES>                                         0
<RECEIVABLES>                                    6,250
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 7,095
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   7,095
<CURRENT-LIABILITIES>                           61,500
<BONDS>                                              0
                                0
                                        219
<COMMON>                                         9,213
<OTHER-SE>                                     993,954
<TOTAL-LIABILITY-AND-EQUITY>                     7,095
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                   71,747
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,502
<INCOME-PRETAX>                                  3,622
<INCOME-TAX>                                       957
<INCOME-CONTINUING>                              2,665
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,665
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission